Linoleic-acid-induced growth suppression induces quiescent cancer cell nests in nude mice

Pathobiology

Volumn 75, Issue 4, 2008, Pages 226-232

  Ohmori, Hitoshi ^a   Sasahira, Tomonori ^a   Fujii, Kiyomu ^a   Yi, Luo ^a   Shimomoto, Takasumi ^a   Kuniyasu, Hiroki ^a,b  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer growth; Linoleic acid; Quiescence

Indexed keywords

BETA ACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LINOLEIC ACID; PROTEIN BAK; PROTEIN BCL 2; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENICITY; CELL AGGREGATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; INOCULATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LINOLEIC ACID; MICE; MICE, INBRED BALB C; MICE, NUDE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 46349101383     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000132383     Document Type: Article

References (38)

1. Gupta RA, Dubois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001;1:11-21.
2. Singh J, Hamid R, Reddy BS: Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 1997;57:3465-3470.
3. Chang WC, Chapkin RS, Lupton JR: Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 1997;18:721-730.
4. Reddy BS, Burill C, Rigotty J: Effect of diets high in ω-3 and ω-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991;51:487-491.
5. Zhou S, Wang G, Chen B, Wang P: Effect of dietary fatty acids on tumorigenesis of colon cancer induced by methyl nitrosourea in rats. J Environ Pathol Toxicol Oncol 2000;19:81-86.
6. Rao CV, Hirose Y, Indranie C, Reddy BS: Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 2001;61:1927-1933.
7. Morotomi M, Sakaitani Y, Satou M, Takahashi T, Takagi A, Onoue M: Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats. Nutr Cancer 1997;27:84-91.
8. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 1998;93:229-240.
9. Belury MA: Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 2002;132:2995-2998.
10. Miller A, Stanton C, Devery R: Cis 9, trans 11- and trans 10, cis 12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells. Anticancer Res 2002;22:3879-3887.
11. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, et al: Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 2003;124:361-367.
12. Fidler IJ: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990;50:6130-6138.
13. Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, et al: Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 2002;62:2162-2168.
14. Kuniyasu H, Yasui W, Kitahara K, Naka K, Yokozaki H, Akama Y, et al: Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. Cell Growth Differ 1997;8:47-52.
15. Sasaki T, Yoshida K, Shimura H, Ichiba M, Sasahira T, Shimomoto T, et al: Inhibitory effect of linoleic acid on transformation of IEC6 intestinal cells by in vitro azoxymethane treatment. Int J Cancer 2006;118:593-599.
16. Vande Berg JS, Robson MC: Arresting cell cycles and the effect on wound healing. Surg Clin North Am 2003;83:509-520.
17. Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G: Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat 1996;41:177-185.
18. Crowley NJ, Seigler HF: Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch Surg 1992;127:1303-1308.
19. Hedley BD, Winquist E, Chambers AF: Therapeutic targets for antimetastatic therapy. Expert Opin Ther Targets 2004;8:527-536.
20. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-153.
21. Murray C: Tumour dormancy: not so sleepy after all. Nat Med 1995;1:117-118.
22. Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VH, Groom AC, et al: Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat 2003;82:199-206.
23. Riethmuller G, Klein CA: Early cancer cells dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin Cancer Biol 2001;11:307-311.
24. Karrison TG, Ferguson DJ, Meier P: Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 1999;91:80-85.
25. Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G: Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 1994;86:45-48.
26. Meltzer A: Dormancy and breast cancer. J Surg Oncol 1990;43:181-188.
27. Demicheli R: Tumor dormancy: findings and hypotheses from clinical research on breast cancer. Semin Cancer Biol 2001;11:297-306.
28. Kuniyasu H, Yasui W, Shinohara H, Yano S, Ellis LM, Wilson MR, et al: Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 2000;157:1523-1535.
29. Sasaki T, Fujii K, Yoshida K, Shimura H, Sasahira T, Ohmori H, et al: Peritoneal metastasis inhibition by linoleic acid with activation of PPARγ in human gastrointestinal cancer cells. Virchows Archiv 2006;448:422-427.
30. Funk CD: The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1996;1304:65-84.
31. Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, et al: Potential use of lipoxygenase inhibitors for cancer chemoprevention. Expert Opin Invest Drugs 2000;9:2121-2138.
32. Duplus E, Forest C: Is there a single mechanism for fatty acid regulation of gene transcription? Biochem Pharmacol 2002;64:893-901.
33. Berger J, Wagner JA: Physiological and therapeutic roles of peroxisome proliferatoractivated receptors. Diabetes Technol Ther 2002;4:163-174.
34. 1 and EGFR. Am J Physiol Gastrointest Liver Physiol 2005;288:G447-G456.
35. Liu JJ, Huang RW, Lin DJ, Peng J, Wu XY, Lin Q, et al: Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-γ ligands induces apoptosis on human myeloid leukemia cells in vitro. Ann Oncol 2005;16:455-459.
36. Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, et al: Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. Faseb J 2002;16:1447-1449.
37. Kuniyasu H, Yoshida K, Sasaki T, Sasahira T, Fujii K, Ohmori H: Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells. Int J Cancer 2006;118:571-576.
38. Uhr JW, Scheuermann RH, Street NE, Vitetta ES: Cancer dormancy: opportunities for new therapeutic approaches. Nat Med 1997;3:505-509.